A new action for topoisomerase inhibitors

This publication has 23 references indexed in Scilit:

• The topoisomerase II inhibitor VM-26 induces marked changes in histone H1 kinase activity, histones H1 and H3 phosphorylation, and chromosome condensation in G2 phase and mitotic BHK cells.
  Journal of Cell Biology, 1990
• DNA topoisomerase II must act at mitosis to prevent nondisjunction and chromosome breakage.
  Molecular and Cellular Biology, 1989
• Flow cytometric analysis of the cellular toxicity of tributyltin
  Toxicology Letters, 1988
• DNA topoisomerase II is required for condensation and separation of mitotic chromosomes in S. pombe
  Cell, 1987
• Cell cycle stage-dependent variations in drug-induced topoisomerase II mediated DNA cleavage and cytotoxicity
  Biochemistry, 1987
• Hypothesis: some mutagens directly alter specific chromosomal proteins (DNA topoisomerase II and peripheral proteins) to produce chromosome stickiness, which causes chromosome aberrations
  Mutagenesis, 1987
• DNA topoisomerase II is required at the time of mitosis in yeast
  Cell, 1985
• Synchronization of murine erythroleukemic cells. Nuclear volume measurements for monitoring cell cycle traverse
  Experimental Cell Research, 1979
• Different drugs arrest cells at a number of distinct stages in G2
  Nature, 1975
• MATHEMATICAL ANALYSIS OF DNA DISTRIBUTIONS DERIVED FROM FLOW MICROFLUOROMETRY
  Journal of Cell Biology, 1974